《临床肿瘤学》.2006年.第20期

......

• Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy for Medullary Thyroid Carcinoma
• CORRESPONDENCE：In Reply
• BRCA1 and BRCA2 Cancer Risks
• In Reply
• Induction of Tolerance in Autoimmune Diseases Rather Than Cure of Cancer by Interleukin-2 Therapy
• In Reply
• Normal CA-125 and the Risk of Progression in Ovarian Cancer
• In Reply
• Optimal Selection of Individuals for BRCA Mutation Testing
• In Reply
• Comparison of Outcomes in Studies of Advanced Hodgkin's Lymphoma
• CORRESPONDENCE：In Reply